969 / 1498
LD-IF-RT in other B-cell malignancies;
results according to histological subtype
Progression Free
(comparions of subgroups)
0
25
50
75
100
0
6
12
18
24
30
36
38
22
13
10
6
3
2
2
30
13
6
3
Time since treatment (months)
Number of patients at risk
PF (%)
indolent any progression
indolent local progression
aggressive any progression
aggressive local progression
Haas et al, EJC 2005